2,484 papers found
Refreshing results…
Delaying surgery for patients with a previous SARS-CoV-2 infection
Recent Developments in Microfluidic ‐Based Point‐of‐care Testing ( POCT ) Diagnoses
Analysis on LoRa RSSI in Urban, Suburban, and Rural Area for Handover Signal Strength-Based Algorithm.
Evaluating patient preference for treatment of positional osa in a crossover randomized controlled trial: CPAP versus a positional therapy device
Barriers to acceptance and uptake of continuous positive airway pressure (CPAP) therapy after a one-month trial among patients with obstructive sleep apnea (OSA)
OP06 Primary care clinicians’ confidence, willingness and participation in advance care planning discussions: a multi-site survey
OP64 Examining patient-reported barriers to talking about advance care planning (ACP) with family physicians: a multi-site survey
Pancreatic cyst surveillance imposes low psychological burden
Priapism associated with lumbar stenosis: case report and literature review
OP29 ‘While my thinking is clear’: outcomes from a feasibility pilot of a multidisciplinary, step-wise pathway for ACP in family medicine
Author Correction: LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer
Anti-Amyloidogenic and Cyclooxygenase Inhibitory Activity of Guettarda speciosa
Gender differences among surgical fellowship program directors
Molecular profiling of non-small cell lung cancer (NSCLC) in Asia with targeted next-generation sequencing (NGS): Interim analysis of a co-operative group study (ATORG-001)
Efficient coupling of a quantum cascade laser to a few-mode chalcogenide fiber: erratum
P1.09-19 High-Throughput Next Generation Sequencing of Treatment-Naïve Non-Squamous NSCLC: The Singapore National Lung Profiling Study
P1.17-07 Neoadjuvant Gefitinib in Resectable Early Stage EGFR Mutant Non-Small Cell Lung Cancer (NSCLC): A Window-of-Opportunity Study
Trilaciclib improves overall survival when given with gemcitabine/carboplatin (GC) in patients with metastatic triple negative breast cancer (mTNBC) in a randomized phase II trial
A phase I study of varlitinib (VAR; ASLAN001) an oral pan-HER tyrosine kinase inhibitor (TKI) combined with mFOLFIRI chemotherapy in advanced solid tumours
P2.14-20 ATORG-003: Dacomitinib With or Without Dose Titration as First-Line Therapy for Metastatic EGFR Mutant Non-Small Cell Lung Cancer (NSCLC)
Missing publications? Read more about our data sources.